30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Anika Therapeutics Takes Major Step in Strategic Transformation with Acquisition of Parcus Medical and Arthrosurface

These implant portfolio acquisitions diversify Anika’s revenue streams across a continuum of care in orthobiologics and sports medicine while positioning the company to expand on a base of fast-growing revenue. Further, Parcus and Arthrosurface fast-track Anika’s buildout of their hybrid salesforce with the addition of 40 direct reps and over 200 distributors.

Armed with these new tools for 2020, Anika looks ready to complete a major step in its five-year strategic plan to become a leader in joint preservation and restoration.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.